Medlive Technology Co., Ltd. · GETTEX:1JZ

Medlive Technology Co., Ltd. financial statements

Medlive Technology Co., Ltd.'s income statement, balance sheet and cash flow, annual and quarterly, each figure dated and linked to the filing it was read from.

Financials

Annual, in CNY

Income statement

LineFY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018
Revenue642.2M558.5M412.0M314.1M284.4M213.5M121.6M83.5M
Cost of revenue256.7M231.2M160.7M101.3M83.7M57.3M44.4M33.6M
Gross profit385.4M327.2M251.3M212.7M200.7M156.2M77.2M49.9M
Research and development76.5M64.6M60.0M46.2M25.3M15.7M15.0M12.2M
Selling, general and administrative182.6M175.6M144.5M122.4M101.8M2.16M2.26M1.79M
Operating income91.9M53.6M19.8M15.2M47.7M87.9M38.0M16.7M
Depreciation and amortization21.1M15.6M9.37M8.99M6.15M5.32M4.83M4.36M
EBITDA113.0M69.2M29.2M24.2M53.9M93.2M42.9M21.0M
Interest expense552.0K786.0K361.0K531.0K535.0K209.0K296.0K439.0K
Income before tax360.3M340.5M253.1M135.0M69.9M104.8M37.0M16.0M
Income tax12.4M10.2M1.37M8.62M24.7M19.7M5.73M1.83M
Net income334.3M315.1M242.3M117.3M40.6M85.2M31.3M14.2M
Earnings per share, basic0.450.430.330.160.060.120.050.02

Balance sheet

LineFY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018
Cash and equivalents2.57B3.84B4.36B4.19B3.88B147.1M38.9M16.5M
Short-term investments1.15B301.2M42.6M29.6M29.6M1.60M1.97M1.45M
Receivables253.6M181.4M155.9M124.2M95.9M58.2M58.9M37.2M
Inventory099.0K199.0K94.0K01.97M
Current assets3.99B4.36B4.57B4.35B4.01B208.4M101.0M56.5M
Property, plant and equipment38.0M11.1M14.6M16.9M15.2M9.18M11.0M
Goodwill192.6M192.5M192.5M111.5M69.7M0
Total assets5.16B5.11B4.89B4.60B4.12B227.1M113.8M69.9M
Accounts payable22.3M13.9M14.8M2.71M6.22M6.26M2.63M2.45M
Current liabilities209.2M207.1M189.8M132.7M113.2M64.1M45.0M30.3M
Total debt10.1M22.6M8.19M11.3M13.2M12.1M4.80M7.37M
Total liabilities230.0M253.6M248.6M171.3M143.4M75.6M47.6M35.0M
Shareholders' equity4.87B4.80B4.60B4.40B3.95B151.4M66.2M35.0M
Shares outstanding736.7M736.3M734.6M736.5M635.8M690.2M690.2M690.2M

Cash flow

LineFY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018
Cash from operations134.5M108.3M101.9M77.2M44.4M111.0M28.2M22.1M
Capital spending-12.8M-20.9M-32.5M-7.49M-1.97M-626.0K-2.43M-3.10M
Free cash flow121.7M87.4M69.3M69.7M42.5M110.4M25.8M19.0M
Cash from investing220.7M111.0M-634.9M-3.59B-50.5M13.0K-2.43M-3.10M
Cash from financing-201.4M-197.9M-133.1M-22.4M3.79B-2.83M-3.43M-5.85M
Dividends paid-185.6M-179.0M-124.7M-12.1M-92.0M-92.0M-92.0M-92.0M
Share buybacks2.25M-683.0K1.00K3.89B
Change in cash65.6M79.1M-603.2M-3.20B3.73B108.2M22.4M13.2M